ELUCENIA
Skip to content
ELUCENIA

Major questions

Under review

Why does the response to immunotherapy vary between patients?

What can help explain response and resistance.

Editorial updateSeptember 25, 2026
Last scientific reviewScientific review not completed
01Available sources

Starting point

The NCI identifies predicting response and resistance as areas of immunotherapy research.

Sources for this section
02Under scientific review

What to investigate

Which tumor and immune response characteristics should be assessed to understand response differences in a defined population?

Sources for this section

LIMITATIONS AND CONTEXT

The scope of this reading

  • The analysis must distinguish immunotherapy modalities, tumor types and outcomes. This question does not establish a universal biomarker.
  • A systematic review of supporting and opposing evidence has not yet been completed; the initial source selection is not exhaustive.

ORIGINAL READING

References and sources

  1. Immunotherapy to Treat CancerNational Cancer Institute / NIH
  2. National Cancer Institute

What would you like to understand?

Search brings together public editorial content and tools. Results retain their review status.